Word

MOBILE LAB

Status

Dead

Status Code

603

Status Date

Thursday, April 8, 2021

Serial Number

88276770

Mark Type

4000

Filing Date

Friday, January 25, 2019

Abandoned Date

Thursday, April 8, 2021

Trademark Owner History

Essenlix Corporation

Classifications

1 Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, namely, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, and diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use

5 Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical testing kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases

10 Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes; Medical diagnostic instruments for the analysis of body fluids in the nature of biological and chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

44 Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the nature of providing information in the fields of health and wellness; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing in the nature of medical testing for treatment purposes, medical diagnostic testing, and wellness services in the nature of providing information in the fields of health and wellness, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample; all of the aforesaid not including medical laboratory services

MOBILE LABORATORY

Trademark Events

Apr 8, 2021

Abandonment Notice Mailed - After Ex Parte Appeal

Apr 8, 2021

Abandonment - After Ex Parte Appeal

Apr 8, 2021

Exparte Appeal Terminated

Feb 23, 2021

Exparte Appeal Dsmsed - Failure To File Brief

Sep 17, 2020

Notification Of Subsequent Final Emailed

Sep 17, 2020

Subsequent Final Emailed

Sep 17, 2020

Subsequent Final Refusal Written

Aug 18, 2020

Ex Parte Appeal-Instituted

Aug 18, 2020

Jurisdiction Restored To Examining Attorney

Aug 10, 2020

Notice Of Revival - E-Mailed

Aug 10, 2020

Exparte Appeal Received At Ttab

Aug 10, 2020

Petition Granted - Ttab Appeal Filed

Aug 10, 2020

Assigned To Petition Staff

Jul 30, 2020

Assigned To Examiner

Jul 29, 2020

Exparte Appeal Received At Ttab

Jul 28, 2020

Teas Response To Office Action Received

Jul 28, 2020

Teas Petition To Revive Received

Jul 28, 2020

Exparte Appeal Received At Ttab

Jun 2, 2020

Abandonment Notice E-Mailed - Failure To Respond

Jun 2, 2020

Abandonment - Failure To Respond Or Late Response

Nov 1, 2019

Notification Of Final Refusal Emailed

Nov 1, 2019

Final Refusal E-Mailed

Nov 1, 2019

Final Refusal Written

Oct 11, 2019

Teas/Email Correspondence Entered

Oct 11, 2019

Correspondence Received In Law Office

Oct 11, 2019

Teas Response To Office Action Received

Apr 11, 2019

Notification Of Non-Final Action E-Mailed

Apr 11, 2019

Non-Final Action E-Mailed

Apr 11, 2019

Non-Final Action Written

Apr 8, 2019

Assigned To Examiner

Feb 17, 2019

New Application Office Supplied Data Entered In Tram

Jan 29, 2019

New Application Entered In Tram